BACKGROUND: To compare half-Fourier acquisition single-shot turbo spin-echo spin-echo (HASTE) magnetic resonance cholangiopancreatography (MRCP) with two-dimensional turbo spin-echo (2D TSE) MRCP for imaging pancreatobiliary diseases. METHODS: Twenty-seven patients with biliary or pancreatic disease underwent MRCP on a 1.0-T scanner with a body phased-array coil. A T2-weighted HASTE sequence (18 s) and a T2-weighted 2D TSE sequence (45 s) were used during a breath-hold by the patient. The source images and maximum intensity projection images of both sequences were reviewed independently by two radiologists. RESULTS: Motion artifacts were more severely pronounced with 2D TSE sequences than with HASTE sequences (p < 0.001). All obstructions and their sites were accurately identified with both sequences. Filling defects (calculi) in bile ducts were identified in all 22 segments (100%) with HASTE-MRCP, whereas calculi in 19 of 22 segments (86%) were identified with 2D TSE-MRCP (p = 0.25). Three missed sites on 2D TSE-MRCP were intrahepatic bile ducts. CONCLUSIONS: HASTE-MRCP is superior to 2D TSE-MRCP in terms of detecting motion artifacts and visualization of the pancreatic ducts. HASTE-MRCP is comparable to 2D TSE-MRCP for visualization of the biliary ducts and their obstruction and is superior to 2D TSE-MRCP for identification of calculi in intrahepatic bile ducts.
BACKGROUND: To compare half-Fourier acquisition single-shot turbo spin-echo spin-echo (HASTE) magnetic resonance cholangiopancreatography (MRCP) with two-dimensional turbo spin-echo (2D TSE) MRCP for imaging pancreatobiliary diseases. METHODS: Twenty-seven patients with biliary or pancreatic disease underwent MRCP on a 1.0-T scanner with a body phased-array coil. A T2-weighted HASTE sequence (18 s) and a T2-weighted 2D TSE sequence (45 s) were used during a breath-hold by the patient. The source images and maximum intensity projection images of both sequences were reviewed independently by two radiologists. RESULTS: Motion artifacts were more severely pronounced with 2D TSE sequences than with HASTE sequences (p < 0.001). All obstructions and their sites were accurately identified with both sequences. Filling defects (calculi) in bile ducts were identified in all 22 segments (100%) with HASTE-MRCP, whereas calculi in 19 of 22 segments (86%) were identified with 2D TSE-MRCP (p = 0.25). Three missed sites on 2D TSE-MRCP were intrahepatic bile ducts. CONCLUSIONS: HASTE-MRCP is superior to 2D TSE-MRCP in terms of detecting motion artifacts and visualization of the pancreatic ducts. HASTE-MRCP is comparable to 2D TSE-MRCP for visualization of the biliary ducts and their obstruction and is superior to 2D TSE-MRCP for identification of calculi in intrahepatic bile ducts.